Sigma Healthcare Ltd (ASX: SIG) Share Price and News

Dr Roberts has more than 40 years experience in the medical device industry, including as the former CEO of Cochlear Limited (ASX:COH) from 2004 to 2015, Executive Vice President of ResMed Inc (NYSE:RMD) from 1992 to 2003 and as a Director until November 2017. He is currently a Non-Executive Director of: HMC Capital managed HealthCo Healthcare and Wellness REIT (ASX: HCW), HMC Capital Partners Fund 1, Clarity Pharmaceuticals Limited (ASX:CU6), Nutromics Pty Ltd, Atmo Biosciences Limited and the Cochlear Foundation Board. He is also a Governor of the Centenary Institute Cancer Medicine and Cell Biology.

Mr Mitchell has financial experience coupled with more than a decade of experience as an active Nonexecutive Director. He is a current Director and Chair of the Audit Committee of Sonic Healthcare and is a Director and Chair of the Audit and Risk Committee of Fisher and Paykel Healthcare and QBiotics. Previously, Mr Mitchell has held other Director roles including South Eastern Sydney Local Health District, The Board of Taxation, Sirtex Medical and Osprey Medical Inc. Prior to becoming a Non-Executive Director, Mr Mitchell had a career spanning 27 years with Cochlear Limited, 22 of those years as Chief Financial Officer and Company Secretary.

Ms Spargo has gained business experience as both an adviser, having worked in private practice and government, and as a director of listed and unlisted companies. Ms Spargo is currently Non-Executive Director at Sonic Healthcare Limited, Adairs Limited, and CIMIC Ltd. Ms Spargo has held as Non-Executive Director in Xenith IP Ltd and Fletcher Building Limited. In addition, Ms Spargo's current positions in unlisted companies include Chairman of CoInvest and Director at the Geelong Football Club and Future Fuels Cooperative Research Centre. She is a Member of Risk Management and People committee.

Mr Sammells is currently a NonExecutive Director at AMP. Mr Sammells has 35 years of experience in finance, corporate services, and has held operational roles with expertise in finance, accounting, treasury, investor relations, capital developments, mergers and acquisitions and IPOs. Mr Sammells is a former Chief Financial Officer of Healthscope Limited and Medibank Private. He is a Chair of Risk Management Committee.

Mr Ramsunder was previously Group CEO of Clicks Group in South Africa, a position he held since January 2019. Prior to becoming Group CEO, Vikesh held a number of roles within the Clicks Group, including Chief Operating Officer from 2015, and Managing Director of United Pharmaceutical Distributors (UPD), the Click Group's pharmaceutical wholesale and distribution division.

Ms Carey is a current Director of National Intermodal Corporation and an Advisory Board Member of Orizontas. Prior to that, Ms Carey has been a Director of Linfox Armaguard Pty Ltd and Sai Cheng Logistics Inc and was Chair of Australia Post Global and BevChain. Ms Carey brings a technical as well as strategic and commercial intellect from over 20 years experience in transport, supply chain and logistics. Ms Carey has previously held various senior roles within Linfox, progressing from General Counsel and Company Secretary to Chief Executive Officer. Ms Carey also held the position of Executive General Manager International with Australia Post.

-

-

-